Abstract

Marine invertebrate-associated symbiotic bacteria produce a plethora of novel secondary metabolites which may be structurally unique with interesting pharmacological properties. Selection of strains usually relies on literature searching, genetic screening and bioactivity results, often without considering the chemical novelty and abundance of secondary metabolites being produced by the microorganism until the time-consuming bioassay-guided isolation stages. To fast track the selection process, metabolomic tools were used to aid strain selection by investigating differences in the chemical profiles of 77 bacterial extracts isolated from cold water marine invertebrates from Orkney, Scotland using liquid chromatography-high resolution mass spectrometry LC-HRMS and nuclear magnetic resonance NMR spectroscopy. Following mass spectrometric analysis and dereplication using an Excel macro developed in-house, principal component analysis PCA was employed to differentiate the bacterial strains based on their chemical profiles. NMR 1H and correlation spectroscopy COSY were also employed to obtain a chemical fingerprint of each bacterial strain and to confirm the presence of functional groups and spin systems. These results were then combined with taxonomic identification and bioassay screening data to identify three bacterial strains, namely Bacillus sp. 4117, Rhodococcus sp. ZS402 and Vibrio splendidus strain LGP32, to prioritize for scale-up based on their chemically interesting secondary metabolomes, established through dereplication and interesting bioactivities, determined from bioassay screening.

Links and resources

Tags

community

  • @cheng1
  • @abdelmohsen
  • @utehentschel
  • @gernert
@abdelmohsen's tags highlighted